1. Home
  2. NBIX vs GL Comparison

NBIX vs GL Comparison

Compare NBIX & GL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$130.52

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Globe Life Inc.

GL

Globe Life Inc.

N/A

Current Price

$152.30

Market Cap

10.7B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NBIX
GL
Founded
1992
1900
Country
United States
United States
Employees
N/A
3695
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
10.7B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NBIX
GL
Price
$130.52
$152.30
Analyst Decision
Strong Buy
Buy
Analyst Count
22
11
Target Price
$180.91
$167.27
AVG Volume (30 Days)
1.1M
428.2K
Earning Date
05-05-2026
04-22-2026
Dividend Yield
N/A
0.71%
EPS Growth
41.95
N/A
EPS
4.67
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$9.64
Revenue Next Year
$13.14
$5.61
P/E Ratio
$27.99
$10.21
Revenue Growth
977.51
N/A
52 Week Low
$107.96
$116.73
52 Week High
$160.18
$155.08

Technical Indicators

Market Signals
Indicator
NBIX
GL
Relative Strength Index (RSI) 51.13 62.75
Support Level $124.62 $135.08
Resistance Level $135.88 $152.71
Average True Range (ATR) 3.58 2.99
MACD -0.12 0.06
Stochastic Oscillator 59.98 67.63

Price Performance

Historical Comparison
NBIX
GL

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

Share on Social Networks: